Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Curr Protoc Hum Genet ; Chapter 12: Unit 12.7, 2007 Jan.
Article in English | MEDLINE | ID: mdl-18428407

ABSTRACT

Retrovirus pseudotype is defined as the genome of one retrovirus encapsidated by the envelope protein of a second virus. The host range of the pseudotype is that of the virus donating the envelope protein. Two procedures that use 293GP cells, which are derived from human kidney 293 cells, are described here. The first is based on the high transient transfection efficiency of 293 cells. The retroviral construct and an expression plasmid for VSV-G are co-transfected into 293GP cells that stably express MLV gag and pol proteins. Transiently generated virus is then harvested during consecutive days following DNA transfection. The second procedure involves stable 293GP cell lines containing the VSV-G gene under the control of a promoter whose activity is regulated by tetracycline. Cell lines containing the retroviral vector of interest are established under noninduced conditions. Infectious virus can be harvested following the induction of VSV-G expression in these cell lines.


Subject(s)
Genetic Vectors , Membrane Glycoproteins/biosynthesis , Retroviridae/genetics , Transduction, Genetic/methods , Viral Envelope Proteins/biosynthesis , Cell Line , Gene Products, pol/genetics , Humans , Membrane Glycoproteins/genetics , Methods , Viral Envelope Proteins/genetics
2.
Endocrinology ; 147(10): 4627-37, 2006 Oct.
Article in English | MEDLINE | ID: mdl-16840547

ABSTRACT

We have demonstrated that S179D prolactin (PRL) is potently antiangiogenic in vivo. Here, we examined apoptosis in human endothelial cells, using procaspase-8 and cytochrome c release as markers of the extrinsic and intrinsic pathways, respectively. Both pathways converge at caspase-3, which is responsible for cleavage of DNA fragmentation factor (DFF45). A 3-d incubation in 50 ng/ml S179D PRL quadrupled the number of early apoptotic cells; this effect was doubled at 100 ng/ml and became maximal at 500 ng/ml. DFF45 and procaspase 8 cleavage were detectable at 100 ng/ml. Cytochrome c, however, was unaffected until 500 ng/ml. The p21 increased at 24 h, whereas a change in p53 required both triple the time and higher doses. The p21 promoter activity was maximal at 50 ng/ml, whereas 500 ng/ml were required to see a significant change in the Bax promoter (a measure of p53 activity). Because S179D PRL and basic fibroblast growth factor (bFGF) have both been shown to activate ERK, the effect of S179D PRL on bFGF-induced ERK signaling was examined. S179D PRL blocked ERK phosphorylation in response to bFGF, whereas continued coincubation caused a delayed and prolonged activation of ERK. PD98059 inhibited this delayed activation of ERK and effects of S179D PRL on all measures except p53 levels or activity of the Bax promoter. We conclude that S179D PRL blocks bFGF-induced ERK signaling and yet uses ERK in a different time frame to elevate p21 and activate the extrinsic pathway. Prolonged incubations and high concentrations additionally activate the intrinsic pathway using an alternate intracellular signal.


Subject(s)
Apoptosis/physiology , Endothelial Cells/physiology , Mitogen-Activated Protein Kinases/physiology , Prolactin/physiology , Signal Transduction/physiology , Annexin A5/metabolism , Blotting, Western , Coloring Agents , Cytochromes c/metabolism , Cytosol/metabolism , DNA/metabolism , DNA Fragmentation , Flow Cytometry , Humans , Immunoblotting , Luciferases/metabolism , Phosphatidylserines/metabolism , Propidium , Tissue Culture Techniques , Transfection , beta-Galactosidase/genetics , beta-Galactosidase/metabolism
3.
BMC Cancer ; 5: 135, 2005 Oct 19.
Article in English | MEDLINE | ID: mdl-16236176

ABSTRACT

BACKGROUND: UV-induced damage can induce apoptosis or trigger DNA repair mechanisms. Minor DNA damage is thought to halt the cell cycle to allow effective repair, while more severe damage can induce an apoptotic program. Of the two major types of UV-induced DNA lesions, it has been reported that repair of CPD, but not 6-4PP, abrogates mutation. To address whether the two major forms of UV-induced DNA damage, can induce differential biological effects, NER-deficient cells containing either CPD photolyase or 6-4 PP photolyase were exposed to UV and examined for alterations in cell cycle and apoptosis. In addition, pTpT, a molecular mimic of CPD was tested in vitro and in vivo for the ability to induce cell death and cell cycle alterations. METHODS: NER-deficient XPA cells were stably transfected with CPD-photolyase or 6-4PP photolyase to specifically repair only CPD or only 6-4PP. After 300 J/m2 UVB exposure photoreactivation light (PR, UVA 60 kJ/m2) was provided for photolyase activation and DNA repair. Apoptosis was monitored 24 hours later by flow cytometric analysis of DNA content, using sub-G1 staining to indicate apoptotic cells. To confirm the effects observed with CPD lesions, the molecular mimic of CPD, pTpT, was also tested in vitro and in vivo for its effect on cell cycle and apoptosis. RESULTS: The specific repair of 6-4PP lesions after UVB exposure resulted in a dramatic reduction in apoptosis. These findings suggested that 6-4PP lesions may be the primary inducer of UVB-induced apoptosis. Repair of CPD lesions (despite their relative abundance in the UV-damaged cell) had little effect on the induction of apoptosis. Supporting these findings, the molecular mimic of CPD, (dinucleotide pTpT) could mimic the effects of UVB on cell cycle arrest, but were ineffective to induce apoptosis. CONCLUSION: The primary response of the cell to UV-induced 6-4PP lesions is to trigger an apoptotic program whereas the response of the cell to CPD lesions appears to principally involve cell cycle arrest. These findings suggest that CPD and 6-4 PP may induce differential biological effects in the UV-damaged cell.


Subject(s)
Apoptosis , DNA Damage , Pyrimidine Dimers/pharmacology , Ultraviolet Rays , Animals , Biopsy , Blotting, Western , Cell Cycle , DNA Repair , Deoxyribodipyrimidine Photo-Lyase/chemistry , Deoxyribodipyrimidine Photo-Lyase/metabolism , Disease Models, Animal , Dose-Response Relationship, Radiation , Flow Cytometry , Humans , In Situ Nick-End Labeling , Jurkat Cells , Mice , Mice, Inbred C57BL , Pyrimidine Dimers/metabolism , Radioimmunoassay , Transfection
4.
BMC Biotechnol ; 2: 5, 2002 Apr 19.
Article in English | MEDLINE | ID: mdl-11964188

ABSTRACT

BACKGROUND: Transgenic animals have become valuable tools for both research and applied purposes. The current method of gene transfer, microinjection, which is widely used in transgenic mouse production, has only had limited success in producing transgenic animals of larger or higher species. Here, we report a linker based sperm-mediated gene transfer method (LB-SMGT) that greatly improves the production efficiency of large transgenic animals. RESULTS: The linker protein, a monoclonal antibody (mAb C), is reactive to a surface antigen on sperm of all tested species including pig, mouse, chicken, cow, goat, sheep, and human. mAb C is a basic protein that binds to DNA through ionic interaction allowing exogenous DNA to be linked specifically to sperm. After fertilization of the egg, the DNA is shown to be successfully integrated into the genome of viable pig and mouse offspring with germ-line transfer to the F1 generation at a highly efficient rate: 37.5% of pigs and 33% of mice. The integration is demonstrated again by FISH analysis and F2 transmission in pigs. Furthermore, expression of the transgene is demonstrated in 61% (35/57) of transgenic pigs (F0 generation). CONCLUSIONS: Our data suggests that LB-SMGT could be used to generate transgenic animals efficiently in many different species.


Subject(s)
Animals, Genetically Modified , Gene Transfer Techniques , Spermatozoa/metabolism , Animals , Antibodies, Monoclonal/metabolism , Cattle , Chickens , Female , Fertilization in Vitro , Goats , Humans , Insemination, Artificial/methods , Male , Mice , Mice, Transgenic , Oviducts/surgery , Sheep , Spermatozoa/immunology , Swine
SELECTION OF CITATIONS
SEARCH DETAIL
...